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Transient myocardial depression associated with intra•
coronary injections of contrast medium has been attrib•
uted to hypertonicity and to calcium binding. To further 
assess the importance of calcium binding, a new tech•
nique for continuous monitoring of coronary sinus ion•
ized calcium with an intravascular calcium-selective 
electrode was used. With this calcium-selective electrode 
the effects of intracoronary injection in dogs of a con•
ventional ionic contrast agent, sodium meglumine dia•
trizoate (Renografin-76), and a new nonionic agent, io•
hexol, were assessed and compared. Left ventricular 
pressure was measured with a micromanometer cathe•
ter. After bolus injection of 0.2 mllkg body weight of 
Renografin-76 (n = 10), coronary sinus pea increased by 
0.27 from 2.98 ± 0.02 to 3.25 ± 0.03, indicating a 
decrease in ionized calcium from 2.0 to 1.1 mEq/liter. 
With iohexol (n = 9), pea increased by only 0.05 ± 0.01 
(p < 0.001), indicating a decrease in ionized calcium 
from 2.0 to 1.8 mEqlIiter. Peak changes occurred ap-
Intracoronary injection of a radiographic contrast medium 
is associated with transient myocardial depression, and this 
negative effect has been attributed to a reduction in serum 
ionized calcium (1-8) and to hypertonicity (7,9-15). Pre-
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proximately 6 seconds after injection. Renografin-76 
caused a marked decrease in left ventricular systolic 
pressure (140 ± 7 to 106 ± 8 mm Hg) and in heart rate 
(122 ± 7 to 101 ± 5 beats/min) with an increase in end•
diastolic pressure (5 ± 1 to 12 ± 1 mm Hg), whereas 
iohexol did not significantly alter these variables. Using 
Renografin-76 with calcium added to achieve an ionized 
calcium level of2 (n=4), 4 (n=4) or 6 (n=4) mEqlIiter, 
the changes in coronary sinus pea were abolished and 
the hemodynamic changes attenuated. 
These findings indicate that Renografin-76 results in 
greater myocardial depression than the new nonionic 
agent iohexoI. This is due largely to lowering of the 
ionized calcium in the coronary circulation resulting 
mainly from calcium binding by the calcium-chelating 
additives in Renografin-76, although hypertonicity also 
plays a role. 
(J Am Coil CardioI198S;6:84S-S3) 
vious investigations of the effects of intracoronary injection 
of contrast medium on coronary sinus ionized calcium (1,5) 
and of the relation between intravascular ionized calcium 
and myocardial function (16,17) have been carried out using 
intermittent sampling techniques. The main disadvantage of 
these techniques is that samples have to be taken over a 
finite period of time so that continuous instantaneous mea•
surements cannot be made and the precise timing of peak 
changes cannot be accurately assessed. In this study we 
used a new technique utilizing a specially constructed in•
travascular calcium-selective electrode to continuously 
monitor changes in coronary sinus ionized calcium asso•
ciated with intracoronary injections of contrast medium in 
closed chest anesthetized dogs, and to correlate these changes 
with alterations in left ventricular hemodynamics. The ef•
fects of a conventional ionic contrast agent, sodium meglu•
mine diatrizoate (Renografin-76), were compared with those 
of a new nonionic agent, iohexol, which has previously 
been shown to have fewer negative inotropic effects than 
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those of conventional ionic agents in dogs (19) and in hu•
mans (20,21). 
Methods 
Experimental preparation. The experiments were car•
ried out in six mongrel dogs weighing 20 to 25 kg, pre•
medicated with ketamine (100 mg intravenously), anesthe•
tized with chloralose (50 mg/kg body weight intravenously) 
stabilized with methane (900 mglkg), intubated with a cuffed 
endotracheal tube and ventilated with a Harvard respirator. 
Through a cutdown over the right carotid artery a 6F 
micromanometer catheter (Millar Instruments) was ad•
vanced into the left ventricle (Fig. 1). The high fidelity 
recording of the left ventricular pressure was matched with 
the pressure measured through the catheter lumen using a 
Statham P23 Db transducer calibrated externally against a 
mercury reference. The first derivative of left ventricular 
pressure (dP/dt) was derived electronically from the micro•
manometer recording. Injections of contrast medium were 
made selectively into the left coronary artery through a 
modified Amplatz coronary artery catheter (Cook) intro•
duced through a cutdown over the right femoral artery. 
Measurement of coronary sinus ionized calcium. The 
coronary sinus was catheterized by way of the right external 
jugular vein using an 8F Teflon catheter, the distal end of 
which was moulded into a suitable curve using steam heat. 
A specially constructed calcium-selective electrode was in•
troduced into this catheter through a side arm adaptor and 
advanced within the catheter so that its tip protruded 1 cm 
from the distal end within the coronary sinus (Fig. 1). The 
construction of the electrode (Fig. 2) is based on that of a 
catheter tip pH electrode used for intravascular measurement 
of pH (22-25). It consists of a 60 to 100 cm length of 
Figure 1. Diagrammatic representation of the experimental model. 
See text. I = 8F coronary sinus (CS) catheter; 2 = intravascular 
calcium electrode; 3 = 6F micromanometer catheter; 4 = left 
coronary artery (LCA) catheter; 5 = reference electrode; LV = 
left ventricle; RA = right femoral artery; SVC = superior vena 
cava. 
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Figure 2. Diagram of the calcium-selective electrode. See text. 
polyvinyl chloride tubing, 1.3 mm in diameter, in the distal 
end of which is a porous ceramic plug covered with a cal•
cium-selective ionophore membrane that has a polyvinyl 
chloride base and forms a seal with the tubing. The ion•
ophore consists of a mixture of calcium bis( 1,1,3 ,3-di-l, 1,3,3-
tetramethylbutylphenyl phosphonate) and di-N-octylphenyl 
phosphonate dissolved in tetrahydrofuran containing poly•
vinyl chloride. The plugged end of the tubing is dipped into 
this solution, which forms a thin membrane after evapo•
ration of the tetrahydrofuran. 
The internal electrolyte consists of an aqueous solution 
of calcium chloride and saturated silver chloride. In contact 
with this electrolyte is the distal (chloride) end of an in•
sulated silver-silver chloride wire, the proximal end of which 
is connected to a digital voltmeter (model pHM84, Radi•
ometer). A Teflon coated guide wire (0.038 inch diameter 
[0.097 cm]) is incorporated into the electrode with its distal 
end 10 cm from the tip of the electrode in order to give 
added stiffness for manipulation of the electrode within the 
catheter while leaving the tip very flexible to minimize the 
chances of perforation of the coronary sinus wall. A ref•
erence calomel electrode (model K4112, Radiometer) is also 
connected to the voltmeter and is inserted in the side arm 
of a three-way stopcock attached to the lumen of the saline•
filled coronary sinus catheter so that it is in contact with the 
blood in the coronary sinus through the column of saline 
solution surrounding the electrode. 
The function of the electrode depends on the measure•
ment of an electric potential difference that is generated by 
the ionophore membrane (26). Ideally, this potential dif•
ference is proportional to the logarithm of the activity of 
calcium ions in the surrounding solution (Nernstian re•
sponse) according to the equation 
[1] 
where Eca is the cell potential, Eo is the reference potential 
at constant temperature, S is the slope of the electrode re•
sponse function and Aca is the activity of the Ca2 + ion in 
simple solution. For an electrode with an ideal Ca2 + re•
sponse, equation [1] corresponds to the Nemst equation 
where the slope Sis 29.58 mY at 37°C. Assuming an ideal 
response, therefore, a lO-fold change in ionized calcium 
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concentration, or I pCa unit, is reflected by a change of 
approximately 30 m V in the measured potential difference. 
In practice, slopes of the electrode response above and below 
this ideal are observed. Electrodes were used only if they 
exhibited at least 90% of an ideal response in test solutions. 
The absolute value of the pCa is defined as the negative 
logarithm of the ionized calcium activity (-logIO (Aca», 
where Aca is expressed in molar units, which is half the 
Normality in equivalents per liter. 
The electrodes were calibrated before use against stan•
dard calcium solutions with 150 mEq/liter of sodium chlo•
ride. During each experiment coronary sinus blood samples 
were taken intermittently for calibration of the catheter elec•
trode using a solid state bench calcium-selective electrode 
(lonetics) . 
Procedure. Bolus injections of 0.2 mllkg of contrast 
medium were made by hand injection into the left coronary 
artery at a rate of approximately 3 mils, care being taken 
to use as consistent a rate and force of injection as possible. 
Continuous recordings were made on a strip chart recorder 
(Electronics for Medicine) of the micromanometer left ven•
tricular pressure, left ventricular dPidt, electrocardiogram 
and coronary sinus ionized calcium before, during and for 
at least 20 seconds after each injection. Paper speed was 
10 to 25 mm/s. 
Injections were made in random order of Renografin-76 
(n = 10), iohexol (n = 9), both containing 370 mg/kg iodine, 
and Renografin-76 with calcium added in sufficient quan•
tities to result in an ionized calcium level of 2 (n = 4), 
4 (n=4) and 6 (n=4) mEq/liter. To achieve a level of 2 
and 6 mEq/liter of ionized calcium, a total of 42 and 63 
200 =---; 
-
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mEq/liter of calcium chloride, respectively, was required. 
To achieve an ionized calcium level of 2 mEq/liter in io•
hexol, less than 2 mEq/liter of calcium chloride was required. 
Statistics. Results are expressed as mean ± standard 
error of the mean. Tests for significance between the iohexol 
and Renografin-76 groups were carried out by analysis of 
variance. 
Results 
Blood ionized c~lcium concentration. Recordings dur•
ing single injections of Renografin-76, iohexol and Reno•
grafin-76 with 6 mEq/liter of ionized calcium are shown in 
Figures 3, 4 and 5. The left ventricular pressure traces and 
the coronary sinus pCa signal are superimposed. For the 
sake of clarity, left ventricular dP/dt traces have been omit•
ted from these figures. An increase in pCa reflects a de•
crease in ionized calcium concentration. Since the level of 
ionized calcium in the blood under control conditions was 
approximately 2 mEq/liter, the peak in pCa of 0.27 with 
Renografin-76 (Fig. 3) reflects a decrease in ionized calcium 
concentration of approximately O. 9 m~q/liter (from 2 to I, I 
mEq/liter). With iohexol, the peak increase in pCa was only 
0.05 (Fig. 4), reflecting a decrease in ionized calcium con•
centration of only 0.2 mEq/liter. After injection of Reno•
grafin-76 with 6 mEq/liter of ionized calcium, there was a 
decrease in pCa of 0.16 (Fig. 5), reflecting an increase in 
ionized calcium concentration of 0.5 mEq/liter. 
The changes in pCa are seen to begin at approximately 
2 seconds after contrast injection, indicating a rapid response 
time of the electrode, which is probably similar to ~pe 300 
0.4 
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Figure 3. Experimental recording of left 
ventricular pressure, electrocardiogram 
(ECG) and pCa with single injections 
of Renografin-76 (above) and iohexol 
(below) in Dog 2. Within seconds after 
the start of the injection of Renografin-
76 the systolic pressure begins to de•
crease with a peak change at 5 to 6 sec•
onds. This is associated with an increase 
in pCa, an increase in left ventricular 
end-diastolic pressure, T wave inver•
sion and increased R wave amplitude. 
Bradycardia was not noted in this dog. 
The changes with iohexol are clearly 
less than with Renografin-76. 
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ms response time of a similarly constructed pH electrode 
(21). The peak changes occur approximately 6 seconds after 
injection with a subsequent slower return toward control 
values. 
Pressure and electrocardiographic changes. Associated 
with these changes in pea there is a marked decrease in left 
ventricular systolic pressure and an increase in left ventricular 
end-diastolic pressure. Again this maximal change occurs 
at about 6 seconds after injection. There were corresponding 
changes in positive and negative left ventricular dP/dt (Table 
1). . 
Electrocardiographic changes were manifested in the ex•
periment illustrated in Figure 3 by T wave inversion and an 
increase in R wave amplitude. In other experiments (Fig. 
4) tbere was an increase in T wave amplitude. Tbe direction 
of the T wave change is related to the lead that is monitored 
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Figure 4. Experimental recordings of left ventricular 
pressure, electrocardiogram (ECG) and pCa with single 
injections of Renografin-76 (above) and iohexol (below) 
in Oog 3. As in Figure 3, the effects of iohexol are clearly 
less than those of Renografin-76. In this experiment the 
electrocardiogram showed increased T wave inversion, 
and there is a marked bradycardia that is not seen with 
iohexol. 
and to the variable coronary artery anatomy in the dogs. 
With most injections there was marked bradycardia as shown 
in Figure 4, but not in Figure 3. 
Effect of Renografin-76 with 6 mEq/liter of added 
calcium (Table 1). With iohexol (Fig. 3 and 4) the changes 
in left ventricular systolic pressure, left ventricular end•
diastolic pressure, left ventricular dP/dt, heart rate and elec•
trocardiogram are clearly smaller than with Renografin-76. 
After injection of Renografin-76 with 6 mEq/liter of added 
calcium (Fig. 5), the decrease in left ventricular systolic 
pressure and increase in left ventricular end-diastolic pres•
sure are attenuated. The corresponding changes in left ven•
tricular dP/dt were also less mar)ced. There is still marked 
slowing of the heart rate but to a lesser degree than with 
Renografin-76 alone. The T wave and R wave amplitude 
changes are less apparent. The mean results (± SE) for the 
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Figure 5. Experimental recordings of left ventricular 
pressure, electrocardiogram (ECG) and pCa with a single 
injection of Renografin-76 in Dog 3, after the addition 
of calcium chloride (63 mEqlliter) to the Renografin-76 
to produce an ionized calcium concentration of 6 mEq/liter. 
There is attenuation of the qecrease in left ventricl.\lar 
systolic pressure and of the increase in left ventricular 
end-diastolic pressure. There are only minor T wave 
changes but there is still marked bradycardia. The changes 
are associated with a decrease in pCa . 
• 
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5 sec. 
JACC Vol. 6, No.4 
October 1985:845-53 
BOURDILLON ET AL 
CORONARY SINUS IONIZED CALCIVM AND CONTRAST 
849 
Table 1. Hemodynamic, Electrocardiographic and Ionized Calcium Changes After Intracoronary Injections of ContraSt Medium 
Contrast LVSP LVEDP* HR T Wave* R Wave* pCa Ca2 + 
Medium n (mmHg) (mmHg) +dP/dt (%) -dP/dt (%) (bpm) (mV x 10) (mV x 10) (x 1(0) (mEqlliter) 
Renografin-76 (R76) 10 36 ± 4 6 ± I -54 ± 5 -44 ± 5 23 ± 7 9.5 ± 2.6 9.5 ± 2.1 +27 ± 3 -0.9 
Iohexol 9 3 ± I§ I ± 0.3§ -5 ± 2§ -9 ± 3§ 2 ± 211 2.50 ± 0.6§ 7 ± I +5 ± I§ -0.2 
R76 + 4 II ± III 2 ± III -21 ± 211 -12 ± 711 6 ± 211 3.5 ± 1.7 5 ± 2 +1 ± III -0.05 
2 mEqlliter Ca2 + 
R76 + 4 15 ± 411 o ± 0.511 -16 ± 14t -13±15t 15 ± 8 7 ± 2+ 13 ± 2:j: -4 ± III +0.2 
4 mEqlliter Ca2 + 
R76 + 4 9 ± 511 2 ± 1.711 +0.5 ± 1211 2 ± 611 22 ± 12 7 ± 2 to ± 2 -9 ± 311 +0.3 
6 mEq/liter Ca2 + 
*Significant dog effect, tn = 3, :j:n = 2; §p = 0.001 (versus R76); lip = 0.01 (versus R76). bpm = beats/min; dP/dt = maximal rate of rise in 
pressure; + = increase; - = decrease; HR = heart rate; L VEDP = left ventricular end-diastolic pressure; L VSP = left ventricular systolic pressure; 
n = number. 
peak changes in these measured variables for the five groups 
of experiments are shown in ,Table 1, The mean changes 
with time after injection are illustrated in Figures 6 to 10, 
There was a highly significant difference between the results 
with Renografin-76 alone and iohexol alone for all the vari•
ables recorded except for the increase in R wave amplitude, 
Addition of calcium to Renografin-76 greatly attenuated the 
changes, 
With 2 mEq/liter of ionized calcium in Renografin-76, 
which approximates the level of ionized calcium in the blood, 
there is virtually no change in pCa (Fig, 9), With 4 (Fig. 
9) and 6 mEq/liter (Fig. 5 and 9) there are progressively 
greater decreases in pCa, corresponding to increases in ion•
ized calcium concentration. 
With 6 mEq/liter of ionized calcium added, the changes 
in left ventricular systolic pressure and end-diastolic pres•
sure are minimal (Fig. 5 and 10). With 4 and 2 mEqlliter 
of added calcium, the changes are slightly greater but still 
considerably less than with Renografin alone. The altera-
Figure 6. Mean changes in pCa with Renografin-76 and iohexol, 
plotted against time after the start of contrast injection. There is 
a highly significant difference between the peak increases in pCa 
(p < 0.001), 
0.3 
0.2 
~pCa 
0.1 
o 
o 5 
• R.nOQrafin 76 (n ~ 10) 
• lohuol (n=9) 
10 
TIME (sec) 
15 20 
tions in heart rate (Fig. 5. Table 1) and in the electrocar•
diogram (Fig. 5) are also diminished with added calcium. 
Discussion 
In this investigation we have shown that the negative 
inotropic and electrocardiographic effects of the new non•
ionic contrast agent, iohexol, are significantly less than those 
of a conventional ionic contrast agent, Renografin-76, which 
is the agent most commonly used for coronary arteriography 
in the United States. This greater toxicity of Renografin-76 
is associated with a greater decrease in the coronary sinus 
ionized calcium concentration as measured by continuous 
intravascular monitoring with a calcium-selective electrode. 
In addition, it has been shown that addition of calcium to 
Renografin-76 in sufficient quantities to result in an ionized 
calcium concentration equivalent to or greater than that in 
Figure 7. Mean changes iri left ventricular systolic pressure and 
end-diastolic pressure with Renografin-76 and iohexol, plotted against 
time after the start of corltrast injection. There is a significant 
difference between the peak decreases in systolic pressure (p < 
0.001) and the peak increases in end-diastolic pressure (p < 0.001). 
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Figdre 8. Mean changes in heart rate with Rertografin-76 and 
iqh~"ol, plotted against time after the start of contrast injection. 
There is a highly significant difference between the peak decreases 
in heart rate (p < 0.001). 
the blood greatly attenuates the myocardial depressive effect 
of this contrast ageot. . 
Advantages of calcium-selective electrode. The main 
advantages of this new technique of corttinuous measure•
ment of coronary sinu~ ionized calcium concentration are 
that even transient small changes associated with bolus intra•
coronary injections of contrast medium can be detected, and 
that the precise timing of these changes can be accurately 
assessed. Correlation between these changes and the changes 
in ,left ventricular hemodynamics can be achieved more ac•
curately than can be done by the intermittent sampling tech-
Figure 9. Mean changes in pCa with Renografin-76 alone and 
after addition of caicium chloride to produce an ionized calcium 
concentration of 2,4 or 6 mEqlliter, respectively, plotted against 
time after the start of contrast injection. The marked increase in 
pCa with Renografin alone is almost abolished with 2 mEq/liter 
Ca2 + , and is progressively reserved with 4 mEq/liter Ca2 + and 6 
mEq/liter Ca2 + . 
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Figure 10. Mean changes in left ventricular systolic pressure and 
end-diastolic pressure with Renografin-76 alone and after addition 
oftalcium chloride to produce an ionized calcium concentration 
of 6 mEqlliter. The decrease in systolic pressure and the increase 
in end-diastolic pressure are clearly attenuated but not abolished 
with the addition of calcium. 
niques used in previous studies (1,5,16). Furthermore, the 
Closed chest dog model used closely simulates the situation 
encountered in clinical practice, and the hemodynamic changes 
observed are more likely to be represehtive of those seen 
during coronary arteriography in patients than those ob•
served in open chest dog models (5,13,14). 
Role of added calcium to contrast medium. The cru•
cial roie of calcium in myocardial contraction was first dem•
onstrated by Ringer in 1883 (27). In 1934, McLean and 
Hastings (28) showed that it is the ionized moiety of the 
total calcium in the blood that is physiologically active. 
Increased calcium levels have been shown to enhance myo•
cardial function (16, l7 ,29,30), and a decrease in plasma 
ionized calcium is known to depress left ventricular function 
(16, l7 ,31-33). The relation between a decrease in coronary 
sinus ionized calcium and the transient myocardial depres•
sion associated with intracoronary injections of contrast me•
dium has been documented in patients (I) and dogs (5). 
Other workers have empirically added calcium to contrast 
agents without measurement of ionized calcium in either 
the contrast agent itself after calcium addition or in the 
coronary sinus after intracoronary injection of the modified 
contrast agent (3,7,9,34,35). It has been previously found 
that addition of calcium reduced the extent of contrast•
induced myocardial depression (3,4,7,34) and increased the 
threshold for ventricular fibrillation (4,36). Tragardh et al. 
(4) found empirically that the optimal amount of calcium 
that should be added to Renografin-76 to attenuate its neg•
ative hemodynamic effects is 40 mEq/liter, which is ap•
proximately the amount that was found in the present study 
JACC Vol. 6, No.4 
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to result in an ionized calcium concentration similar to that 
in blood. Popio et al. (7) also added 40 mEq/liter of calcium 
to Renografin-76 to reduce its negative hemodynamic effects 
in intact dogs. 
Mechanism of decreased blood calcium by contrast 
medium. The primary cause of the decrease in ionized 
calcium in the blood after injection of Renografin-76 is likely 
to be due to the sodium citrate (0.32%) and disodium edetate 
(0.04%) additives. These agents are added as a buffer and 
to absorb any free heavy metals, including copper, but are 
also known to bind calcium so that free ionized calcium is 
reduced. This mechanism has been suggested as a cause of 
the decrease in coronary sinus ionized calcium associated 
with intracoronary injections of Renografin-76 in patients 
(1). It is unclear, however, whether there is also significant 
binding of calcium by the diatrizoate in Renografin-76. 
Thomson et al. (35) observed that after addition of calcium 
(48 mEq/liter) to Renografin-76 a white precipitate slowly 
formed, and they suggested that this may indicate that there 
is calcium binding by the constituents of Renografin-76 
distinct from the sodium citrate and disodium edetate. We 
have observed a similar phenomenon, but injections of Reno•
grafin-76 with added calcium in this series of experiments 
were made before any precipitate was visible. 
Other causes of deleterious myocardial effects of con•
trast medium. Although calcium binding clearly plays a 
role in the cardiotoxicity of Renografin-76, it is also apparent 
that this factor alone cannot account for all of the observed 
hemodynamic and electrocardiographic effects. Even after 
the addition of calcium to an ionized calcium level of 6 
mEq/liter, intracoronary injection of Renografin-76 results 
in definite deleterious hemodynamic, chronotropic and 
electrocardiographic changes, despite a small increase in 
coronary sinus ionized calcium concentration (Fig. 5,9 and 
10; Table 1). Although the changes are clearly attenuated 
with added calcium there is still a marked transient brady•
cardia. The findings are in general agreement with those of 
Popio et al. (7), who concluded that hyperosmolality is 
primarily responsible for the deleterious electrocardio•
graphic effects of Renografin-76 while hypocalcemia in•
duced by calcium-chelating agents is at least partly respon•
sible for the hemodynamic effects. 
It appears to be established that hyperosomolality of con•
trast medium is responsible for a variety of electrophysio•
logic changes (7,11,12,37-40) but the effects of hyperos•
molality on left ventricular contractility are controversial 
(7,41-47). The type of hyperosmolar solution is important 
since hyperosmolar salt solutions have a distinctly negative 
inotropic effect (41), whereas hyperosmolality as such may 
not be an important factor since hyperosmolar solutions of 
sugar caused either no effect or a positive inotropic effect 
(7) and hypertonic mannitol has a positive inotropic effect 
(44). Studies in cat papillary muscles (45-47) suggested 
that solutions with osmolalities up to 330 to 500 mOsmoVliter 
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have a positive inotropic effect, while solutions of a higher 
osmolality have a negative inotropic effect. 
It seems likely that the lower osmolality of iohexol (880 
mOsmollkg) compared with that of Renografin-76 (1,680 
mOsmlkg) has some role in the decrease in hemodynamic 
changes, although this reduction in hemodynamic effects 
may be partly secondary to a reduction in electrophysiologic 
and chronotropic effects. The positive inotropic effect of 
three non ionic agents distinct from iohexol reported by Hig•
gins et al. (13) in open chest dogs was not observed in this 
study. Gerber et al. (3) did not observe the small decrease 
in coronary sinus ionized calcium described in our study 
with iohexol. This difference is presumably due to the more 
sensitive technique of continuous monitoring of ionized cal•
cium used in our study. Our use of a closed chest model 
may to some extent account for the difference in hemody•
namic effects observed. The small decrease in coronary 
sinus ionized calcium with iohexol is probably due in part 
to dilution effects and in part to a minor degree of calcium 
binding by the calcium sodium edetate (0.01 %) that is added 
to the commercially prepared iohexol. 
Like iohexol, other new non ionic and ionic dimeric con•
trast agents have been reported to produce significantly less 
myocardial depression than that produced by Renografin-
76 (4,15,48-51). It is likely that the lower osmolality of 
these agents contributes to this difference. 
Clinical implications. In clinical practice the transient 
depression of left ventricular function associated with intra•
coronary injections of contrast medium does not usually 
result in important complications. Nevertheless, it seems 
logical to minimize the risk of complications arising from 
contrast injections by using the least toxic agents available. 
This may be particularly important for patients who are 
especially at risk, including those with severe three-vessel 
coronary artery disease or left main coronary artery disease, 
those with severe impairment of left ventricular function 
and those with congenital heart disease (especially small 
children and infants). The effect of direct ventriculography, 
in which larger volumes of contrast medium are used, may 
be particularly important in such patients. 
It is possible that methylglucamine diatrizoate, the basic 
formulation of Renografin-76, would cause less myocardial 
depression if the additive, sodium citrate, were omitted. It 
has been shown (6) in dogs that the threshold for ventricular 
fibrillation is lowered less with this formulation with only 
calcium disodium edetate (0.01 %) as an additive than with 
Renografin-76. Even after removal of the calcium chelating 
agents (38), or after addition of calcium as in this study and 
as reported by other workers (3,4,7), the effects of hyper•
osmolality remain, including particularly the electrophys•
iologic effects and the effects on fluid balance and renal 
function that may result from a significant osmotic load. 
The addition of calcium alone is unlikely to prove a satis•
factory solution. Apart from the problem posed by the pre-
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cipitates that may form (6,39), it would seem more logical 
to omit the chelating agents in the first place. 
Conclusion. The changes in ionized calcium in the coro•
nary circulation associated with intracoronary injections of 
the conventional ionic contrast agent Renografin-76 con•
tribute to its myocardial depressive effects, although the 
relative importance of the decrease in ionized calcium and 
hyperosmolality remains to be determined. The use of non•
ionic agents in cardiac angiography is likely to be an im•
portant advance in the investigation of patients with heart 
disease. 
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